How Many Doses Vial PE-22-28? — Dosing & Storage Guide

A single PE-22-28 vial doesn't deliver a fixed number of doses. The yield depends on reconstitution volume, target concentration per administration, and storage protocol. Most researchers assume the lyophilized peptide determines dose count, but the dilution ratio you choose during reconstitution is what actually controls how many administrations you can extract from one vial. Reconstitute a 5mg vial with 1mL bacteriostatic water and you get 5mg/mL; use 2mL and you halve the concentration to 2.5mg/mL. Which doubles the volume required per dose and cuts your total dose count in half.

We've worked with research teams across cellular biology and metabolic pathways who've learned this the expensive way. The gap between efficient yield and compound waste comes down to three factors most peptide guides never mention: calculating target molarity before mixing, matching syringe precision to concentration, and understanding that every temperature excursion above 8°C after reconstitution degrades potency you can't recover.

How many doses can you get from a PE-22-28 vial?

A standard PE-22-28 vial containing 5mg lyophilized peptide yields 10–20 research administrations depending on reconstitution volume and per-dose target amount. If reconstituted to 5mg/mL and each administration requires 250mcg, the vial delivers 20 doses. At 500mcg per dose from the same concentration, yield drops to 10 doses. The peptide amount is fixed. Dose count is determined by dilution strategy and protocol requirements.

Understanding PE-22-28 Vial Composition and Reconstitution Variables

PE-22-28 arrives as a lyophilized powder in sealed glass vials, typically containing 5mg of peptide per vial with excipients like mannitol or trehalose to stabilize the amino acid structure during freeze-drying. The lyophilization process removes water under vacuum at subzero temperatures, leaving a porous cake that must be reconstituted with bacteriostatic water before use. The reconstitution volume you choose. 1mL, 2mL, or 5mL. Directly controls final concentration and therefore how many doses vial PE-22-28 can deliver.

Calculate target concentration before adding solvent: divide total peptide mass by desired volume. A 5mg vial reconstituted with 1mL bacteriostatic water yields 5mg/mL or 5000mcg/mL. If your protocol calls for 250mcg per administration, divide 5000mcg by 250mcg to get 20 doses. Use 2mL solvent instead and concentration drops to 2.5mg/mL. Now each 250mcg dose requires 0.1mL volume instead of 0.05mL, and total yield remains 20 doses but with doubled injection volume per administration.

Our team has found that researchers often choose reconstitution volume based on syringe precision rather than peptide chemistry. Insulin syringes measure in 0.01mL increments. Accurate for volumes above 0.05mL but prone to measurement error below that threshold. If your protocol requires 100mcg doses from a 5mg/mL solution, you'd need to draw 0.02mL per dose. Beyond most standard syringe precision. Dilute to 2mg/mL instead and the same 100mcg dose requires 0.05mL, which falls within reliable measurement range. This is the reconstitution variable most peptide suppliers never explain.

How Storage Protocol Affects PE-22-28 Dose Viability

Lyophilized PE-22-28 remains stable at −20°C for 12–24 months before reconstitution. Once mixed with bacteriostatic water, the peptide must be refrigerated at 2–8°C and used within 28 days. After that window, oxidative degradation and bacterial growth risk compromise potency even if the solution appears clear. The 28-day limit isn't arbitrary: bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which inhibits bacterial proliferation but doesn't prevent it indefinitely.

Temperature excursions above 8°C cause irreversible protein denaturation that neither visual inspection nor home potency testing can detect. A reconstituted vial left at room temperature for six hours may look identical to properly stored peptide, but enzymatic assays consistently show 15–30% potency loss from that single thermal event. This is why calculating how many doses vial PE-22-28 yields must account for storage adherence. A vial that should deliver 20 doses only delivers 14–17 functional doses if stored improperly.

Our experience shows that most peptide degradation happens during the reconstitution process itself, not storage. Injecting air into the vial while drawing solution creates positive pressure that forces contaminants back through the needle during subsequent draws. The correct technique: inject air equal to the volume you'll withdraw, then invert the vial and draw without removing the needle. This maintains neutral pressure and prevents backflow contamination that shortens the 28-day usable window.

PE-22-28 Dosing Calculations: Concentration, Volume, and Administration Frequency

Peptide dosing operates on mass per administration, not volume. A research protocol might specify 500mcg PE-22-28 per administration. That's the target mass regardless of concentration. If your reconstituted solution is 5mg/mL (5000mcg/mL), each 500mcg dose requires 0.1mL volume. Dilute the same vial to 2mg/mL and the same 500mcg dose now requires 0.25mL volume. The peptide amount administered remains constant; volume changes based on how you reconstituted.

Researchers working with low-dose protocols (100–250mcg per administration) often reconstitute to higher concentrations (5mg/mL or greater) to minimize injection volume and reduce the number of freeze-thaw cycles if aliquoting. High-dose protocols (500mcg or more per administration) benefit from lower concentrations (2–2.5mg/mL) because the resulting volumes are easier to measure accurately with standard insulin syringes. This is the dose-volume relationship that determines how many doses vial PE-22-28 practically delivers in your specific protocol.

Administration frequency compounds these calculations. If a protocol calls for 250mcg twice weekly, a 5mg vial reconstituted to 5mg/mL delivers 20 individual doses. But those 20 doses represent 10 weeks of research if administered on a twice-weekly schedule. Plan reconstitution timing around your administration calendar: reconstituting the full vial at once risks exceeding the 28-day viability window if your protocol spans 10+ weeks. Aliquot into smaller volumes and freeze unused portions at −20°C instead, thawing one aliquot at a time as needed.

PE-22-28 Vial Yield: Concentration-Based Comparison

This table shows that total dose count from a PE-22-28 vial remains constant across reconstitution volumes when dose mass stays fixed. But practical usability changes dramatically. Higher concentrations require smaller draw volumes that challenge syringe precision; lower concentrations increase injection volume and bacteriostatic water exposure per dose.

What If: PE-22-28 Dosing Scenarios

What If I Need to Split a Vial Across Multiple Research Phases?

Reconstitute the full vial to your target concentration, then aliquot into sterile cryovials in single-use or weekly-use volumes and freeze at −20°C. Thaw one aliquot at a time as needed. Peptides tolerate one freeze-thaw cycle with minimal degradation (<5% potency loss) but degrade exponentially with repeated thawing. Label each aliquot with reconstitution date and concentration to avoid dosing errors months later.

What If My Protocol Requires 100mcg Doses But I Only Have Insulin Syringes?

Reconstitute to 2mg/mL instead of 5mg/mL. This brings your 100mcg dose volume to 0.05mL, which is the lower limit of reliable insulin syringe accuracy. Alternatively, switch to a 0.3mL or 0.5mL insulin syringe with finer graduation marks (0.005mL increments) if working with higher concentrations. Never estimate volumes below your syringe's precision threshold. Measurement variance at 0.02mL can exceed 20%, turning a 100mcg dose into 80–120mcg.

What If I Accidentally Left Reconstituted PE-22-28 at Room Temperature Overnight?

The peptide has likely experienced 15–30% potency degradation from thermal denaturation. Refrigerate it immediately but do not rely on it for dose-sensitive protocols. You cannot reverse protein unfolding once it occurs. If this was early in the 28-day window and your research tolerates potency variance, continue using it with the understanding that effective concentration is now lower than calculated. For critical work, discard and reconstitute a fresh vial.

The Practical Truth About PE-22-28 Vial Yield

Here's the honest answer: most peptide vial yield charts online assume perfect reconstitution technique, zero measurement error, and ideal storage conditions. In practice, how many doses vial PE-22-28 delivers depends less on the peptide itself and more on your reconstitution math, syringe precision, and whether you're splitting the vial across multiple weeks. A 5mg vial theoretically yields 20 doses at 250mcg each. But if you're drawing with a syringe that can't accurately measure below 0.05mL, or if you exceed the 28-day post-reconstitution window, your functional yield drops to 14–16 doses even though peptide remains in the vial.

The variable no supplier mentions: bacteriostatic water itself. The 0.9% benzyl alcohol preservative extends viability to 28 days, but it also causes mild injection site irritation that scales with volume. Reconstitute to 1mg/mL and each 500mcg dose delivers 0.5mL bacteriostatic water subcutaneously. That's enough to cause stinging, redness, and delayed absorption in some research models. This is why experienced researchers balance concentration against injection volume tolerance rather than maximizing dose count per vial.

Our team has seen researchers waste entire vials by reconstituting at concentrations their syringes couldn't accurately measure. The math works on paper. 5mg at 5mg/mL gives you 1mL total volume for 20 doses of 0.05mL each. But draw 0.05mL with an insulin syringe twenty times and cumulative measurement error means your last few "doses" contain 30–40% less peptide than the first. Reconstitute to 2.5mg/mL instead and double your draw volume to 0.1mL per dose. Measurement variance drops below 5% and you get the full 20 functional doses you calculated.

High-purity research peptides demand precision throughout the entire workflow. At Real Peptides, every PE-22-28 vial undergoes third-party HPLC verification before shipping to confirm the labeled peptide mass matches the actual content within 2%. Because reconstitution math only works if you start with the exact mass you think you have. Explore our full peptide collection to see how small-batch synthesis and exact amino acid sequencing translate to consistent, reliable research outcomes across your entire protocol.

Reconstitution isn't complicated. But it is unforgiving. One calculation error, one improper storage event, or one under-precision syringe turns a 20-dose vial into 12 usable administrations. Count your doses before you mix, match your concentration to your measurement tools, and store at 2–8°C without exception. That's how you extract every dose a PE-22-28 vial can deliver.